ask="6.93"
ask_size="200"
average_daily_volume="857395"
bid="6.85"
bid_size="1000"
book_value="0.05"
change="+0.52"
change_from_200_day_moving_average="2.39"
change_from_50_day_moving_average="0.91"
change_from_52_week_high="-3.36"
change_From_52_week_low="5.25"
change_in_percent="+8.18%"
close="6.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46336000"
high="6.91"
high_52_weeks="10.24"
last_trade_date="1/4/2017"
last_trade_price="6.88"
last_trade_size="73063"
last_trade_time="4:00pm"
low="6.20"
low_52_weeks="1.63"
market_capitalization="507.46M"
moving_average_200_day="4.49"
moving_average_50_day="5.97"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="6.42"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+53.20%"
percent_change_from_50_day_moving_average="+15.27%"
percent_change_from_52_week_high="-32.81%"
percent_change_from_52_week_low="+322.09%"
previous_close="6.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="117.78"
price_per_sales="21.35"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="13.23"
stock_exchange="NMS"
symbol="BCRX"
volume="916176"
weeks_range_52="1.63 - 10.24"
